Matches in SemOpenAlex for { <https://semopenalex.org/work/W1835830368> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W1835830368 endingPage "1135" @default.
- W1835830368 startingPage "1128" @default.
- W1835830368 abstract "To evaluate irinotecan (CPT-11; Yakult Honsha, Tokyo, Japan) in patients with metastatic colorectal carcinoma that had recurred or progressed following fluorouracil (5-FU)-based therapy.Patients were treated with irinotecan 125 to 150 mg/m2 intravenously (IV) every week for 4 weeks, followed by a 2-week rest. Forty-eight patients were entered onto the study and all were assessable for toxicity. Forty-three patients completed one full course of therapy and were assessable for response.One complete and nine partial responses were observed (response rate, 23%; 95% confidence interval [CI], 10% to 36%). The median response duration was 6 months (range, 2 to 13). The median survival time was 10.4 months and the 1-year survival rate was 46% (95% CI, 39% to 53%). Grade 4 diarrhea occurred in four of the first nine patients (44%) treated on this study at the 150-mg/m2 dose level. The study was amended to reduce the starting dose of irinotecan to 125 mg/m2. At this dose, nine of 39 patients (23%) developed grade 4 diarrhea. Aggressive administration of loperamide also reduced the incidence of grade 4 diarrhea. Grade 4 neutropenia occurred in eight of 48 patients (17%), but was associated with bacteremia and sepsis in only case.Irinotecan has significant single-agent activity against colorectal cancer that has progressed during or shortly after treatment with 5-FU-based chemotherapy. The incidence of severe diarrhea is reduced by using a starting dose of irinotecan 125 mg/m2 and by initiating loperamide at the earliest signs of diarrhea. These results warrant further clinical evaluation to define the role of irinotecan in the treatment of individuals with colorectal cancer." @default.
- W1835830368 created "2016-06-24" @default.
- W1835830368 creator A5000168753 @default.
- W1835830368 creator A5010463088 @default.
- W1835830368 creator A5014910217 @default.
- W1835830368 creator A5014937057 @default.
- W1835830368 creator A5019498648 @default.
- W1835830368 creator A5034936183 @default.
- W1835830368 creator A5063294358 @default.
- W1835830368 creator A5071938679 @default.
- W1835830368 creator A5072308451 @default.
- W1835830368 creator A5073398031 @default.
- W1835830368 creator A5075492015 @default.
- W1835830368 creator A5079101064 @default.
- W1835830368 creator A5080900202 @default.
- W1835830368 creator A5083381459 @default.
- W1835830368 creator A5085418762 @default.
- W1835830368 date "1996-04-01" @default.
- W1835830368 modified "2023-10-06" @default.
- W1835830368 title "Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer." @default.
- W1835830368 doi "https://doi.org/10.1200/jco.1996.14.4.1128" @default.
- W1835830368 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8648367" @default.
- W1835830368 hasPublicationYear "1996" @default.
- W1835830368 type Work @default.
- W1835830368 sameAs 1835830368 @default.
- W1835830368 citedByCount "339" @default.
- W1835830368 countsByYear W18358303682012 @default.
- W1835830368 countsByYear W18358303682013 @default.
- W1835830368 countsByYear W18358303682014 @default.
- W1835830368 countsByYear W18358303682015 @default.
- W1835830368 countsByYear W18358303682016 @default.
- W1835830368 countsByYear W18358303682017 @default.
- W1835830368 countsByYear W18358303682018 @default.
- W1835830368 countsByYear W18358303682019 @default.
- W1835830368 countsByYear W18358303682020 @default.
- W1835830368 countsByYear W18358303682021 @default.
- W1835830368 countsByYear W18358303682022 @default.
- W1835830368 countsByYear W18358303682023 @default.
- W1835830368 crossrefType "journal-article" @default.
- W1835830368 hasAuthorship W1835830368A5000168753 @default.
- W1835830368 hasAuthorship W1835830368A5010463088 @default.
- W1835830368 hasAuthorship W1835830368A5014910217 @default.
- W1835830368 hasAuthorship W1835830368A5014937057 @default.
- W1835830368 hasAuthorship W1835830368A5019498648 @default.
- W1835830368 hasAuthorship W1835830368A5034936183 @default.
- W1835830368 hasAuthorship W1835830368A5063294358 @default.
- W1835830368 hasAuthorship W1835830368A5071938679 @default.
- W1835830368 hasAuthorship W1835830368A5072308451 @default.
- W1835830368 hasAuthorship W1835830368A5073398031 @default.
- W1835830368 hasAuthorship W1835830368A5075492015 @default.
- W1835830368 hasAuthorship W1835830368A5079101064 @default.
- W1835830368 hasAuthorship W1835830368A5080900202 @default.
- W1835830368 hasAuthorship W1835830368A5083381459 @default.
- W1835830368 hasAuthorship W1835830368A5085418762 @default.
- W1835830368 hasConcept C121608353 @default.
- W1835830368 hasConcept C126322002 @default.
- W1835830368 hasConcept C141071460 @default.
- W1835830368 hasConcept C2776694085 @default.
- W1835830368 hasConcept C2777063308 @default.
- W1835830368 hasConcept C2777573665 @default.
- W1835830368 hasConcept C2779802037 @default.
- W1835830368 hasConcept C2780259306 @default.
- W1835830368 hasConcept C526805850 @default.
- W1835830368 hasConcept C71924100 @default.
- W1835830368 hasConcept C90924648 @default.
- W1835830368 hasConceptScore W1835830368C121608353 @default.
- W1835830368 hasConceptScore W1835830368C126322002 @default.
- W1835830368 hasConceptScore W1835830368C141071460 @default.
- W1835830368 hasConceptScore W1835830368C2776694085 @default.
- W1835830368 hasConceptScore W1835830368C2777063308 @default.
- W1835830368 hasConceptScore W1835830368C2777573665 @default.
- W1835830368 hasConceptScore W1835830368C2779802037 @default.
- W1835830368 hasConceptScore W1835830368C2780259306 @default.
- W1835830368 hasConceptScore W1835830368C526805850 @default.
- W1835830368 hasConceptScore W1835830368C71924100 @default.
- W1835830368 hasConceptScore W1835830368C90924648 @default.
- W1835830368 hasIssue "4" @default.
- W1835830368 hasLocation W18358303681 @default.
- W1835830368 hasLocation W18358303682 @default.
- W1835830368 hasOpenAccess W1835830368 @default.
- W1835830368 hasPrimaryLocation W18358303681 @default.
- W1835830368 hasRelatedWork W123831250 @default.
- W1835830368 hasRelatedWork W1607296981 @default.
- W1835830368 hasRelatedWork W2038765960 @default.
- W1835830368 hasRelatedWork W2098822886 @default.
- W1835830368 hasRelatedWork W2350204259 @default.
- W1835830368 hasRelatedWork W2351335108 @default.
- W1835830368 hasRelatedWork W2357684900 @default.
- W1835830368 hasRelatedWork W2390365322 @default.
- W1835830368 hasRelatedWork W2424086629 @default.
- W1835830368 hasRelatedWork W3209009327 @default.
- W1835830368 hasVolume "14" @default.
- W1835830368 isParatext "false" @default.
- W1835830368 isRetracted "false" @default.
- W1835830368 magId "1835830368" @default.
- W1835830368 workType "article" @default.